Platelet function in dogs with congenital portosystemic shunt

Area of Science:

• Veterinary Medicine
• Hematology
• Canine Pathophysiology

Background:

• Congenital portosystemic shunts (CPSS) are vascular anomalies affecting canine health.
• The impact of CPSS on primary hemostasis, particularly platelet function, requires further investigation.

Purpose of the Study:

• To evaluate the influence of untreated CPSS on primary hemostasis in dogs.
• To compare platelet function and aggregation in dogs with CPSS versus healthy controls.

Main Methods:

• Assessed bleeding time, platelet counts, and automated platelet function analysis (PFA 100).
• Measured platelet aggregation using impedance and turbidimetric methods with various agonists (collagen, arachidonic acid, ADP).
• Compared data from 10 dogs with CPSS and 10 age-matched healthy controls.

Main Results:

• No significant differences in bleeding time, PFA 100 results, or platelet counts between groups.
• Impedance aggregometry showed reduced aggregation with high collagen and arachidonic acid concentrations in CPSS dogs (P<0.05).
• Turbidimetric aggregometry indicated slightly higher collagen-induced aggregation in CPSS dogs.

Conclusions:

• Dogs with CPSS exhibit moderately altered platelet aggregation patterns.
• Despite aggregation changes, global primary hemostasis screening tests remain unaffected.
• CPSS does not appear to cause clinically relevant primary hemostasis disorders in dogs.